HLHan Liu

Han Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Han Liu has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Chongqi Tu

    Department of Orthopedics, Orthopaedic Research Institute, West China Hospital, Sichuan University, Chengdu, China

    2 shared publications
  • Fan Tang

    Department of Orthopedics, Orthopeadic Research Institute, West China Hospital, West China Medical School Sichuan University Chengdu Sichuan China

    2 shared publications
  • Jianhua Mu

    Department of Orthopedics, Orthopedic Research Institute, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, China

    2 shared publications
  • Minxun Lu

    Department of Orthopedics, Orthopeadic Research Institute, West China Hospital, West China Medical School Sichuan University Chengdu Sichuan China

    2 shared publications
  • Xuanhong He

    Department of Orthopedics, Orthopeadic Research Institute, West China Hospital, West China Medical School Sichuan University Chengdu Sichuan China

    2 shared publications
  • Yi Luo

    Department of Orthopedics, Orthopeadic Research Institute, West China Hospital, West China Medical School Sichuan University Chengdu Sichuan China

    2 shared publications

Latest Publications

  • Open Access

    Development and Validation of an Interpretable Machine Learning Model for Predicting Early Pulmonary Metastasis Risk in Osteosarcoma

    by Jianhua Mu, Yitian Wang, Han Liu, Xuanhong He, Zhuangzhuang Li, Yi Luo, Yong Zhou, Minxun Lu, Fan Tang, Li Min, et al.

    Introduction: Pulmonary metastasis in high‐grade conventional osteosarcoma remains a leading cause of treatment failure and mortality. Traditional monitoring methods are insufficient for early detection. This study aims to develop and validate an interpretable machine learning (ML) model using multi‐dimensional data from electronic medical records (EMR) to predict the early risk of pulmonary metastasis in high‐grade conventional osteosarcoma patients. Methods: This retrospective study included data from 522 high‐grade conventional osteosarcoma patients. After rigorous feature selection, 12 independent predictive factors were identified: prothrombin time (PT), international normalized ratio (INR), fibrinogen, globulin, prognostic nutritional index (PNI), eosinophil percentage, monocyte percentage, neutrophil percentage, monocyte count, maximum tumor diameter, gender, and amputation status. Eleven ML models were constructed and compared, with Shapley Additive Explanations (SHAP) analysis applied to enhance model interpretability and clinical transparency. Results: The gradient boosting model exhibited superior performance, achieving an area under the curve (AUC) of 0.891 in the training set and 0.742 in the independent test set. SHAP analysis revealed that tumor maximum diameter was the most influential predictor of pulmonary metastasis risk, while inflammation and coagulation‐related indicators also demonstrated significant contributions. Discussion: The gradient boosting model effectively predicts the early risk of pulmonary metastasis in high‐grade conventional osteosarcoma and provides interpretable risk factors. This model shows potential as a clinical decision support tool, facilitating personalized risk management and precision medicine, aiming to improve patient outcomes.

  • Open Access

    A Novel 3D ‐Printed Strut‐Type Prosthesis Reconstructs the Hemicortical Defect After Distal Femur Parosteal Osteosarcoma Resection: The Mid‐Term Follow‐Up Outcome

    by Jianhua Mu, Yitian Wang, Han Liu, Xuanhong He, Zhuangzhuang Li, Minxun Lu, Fan Tang, Yi Luo, Yong Zhou, Li Min, et al.

    Background: Parosteal osteosarcoma (PAOS) is a rare and low‐grade primary bone malignant tumor that typically occurs in the distal femur. Traditional reconstruction options for distal femur PAOS include distal femoral replacement (DFR), autografts, and allografts, but issues such as functional sacrifice, insufficient mechanical strength, and low bone union rate limit their further clinical application. 3D‐printed prosthesis, due to the matching shape of various bone defects, could be a novel strategy to reconstruct the hemicortical defect after distal femur PAOS tumor resection. In this study, we designed a 3D‐printed strut‐type prosthesis (3DPSP) to repair the hemicortical defect and evaluated the mid‐term effect in distal femur PAOS. Methods: A retrospective analysis was conducted on patients diagnosed with PAOS at the distal femur between April 2018 and January 2021. Six patients received DFR and six patients received customized 3DPSP reconstruction. Clinical outcomes including oncology status, defect lengths, and ranges of motion of the knee, Musculoskeletal Tumor Society (MSTS) scores, and complications were recorded. X‐ray was performed to evaluate the position and stability of the prosthesis and T‐SMART was applied to assess the interface osteointegration between prosthesis and bone. Results: A total of 12 patients were enrolled in this study with an average follow‐up of 42.1 ± 11.8 months, ranging from 22 to 59 months. In the 3DPSP group, the average operation time was 2.3 ± 0.4 h; the intraoperative blood loss was 175.0 ± 82.2 mL. The average range of motion of the knee was 0°–123° and the mean MSTS score was 28.3 ± 1.6. Compared to the DFR group, the 3DPSP group exhibited significantly less intraoperative blood loss and superior functional recovery. Conclusions: In this study, we designed a novel 3DPSP to reconstruct the hemicortical defect after distal femur PAOS resection. The mid‐term follow‐up result demonstrated that this prosthesis could be an effective reconstruction option for distal femur PAOS patients because of the restored limb function and favorable bone‐prosthesis integration. Further observation of this novel prosthesis is needed.